269 related articles for article (PubMed ID: 29153290)
1. Locally advanced pancreatic cancer: An emerging entity.
O Kane GM; Knox JJ
Curr Probl Cancer; 2018; 42(1):12-25. PubMed ID: 29153290
[TBL] [Abstract][Full Text] [Related]
2. Ablation treatments in unresectable pancreatic cancer.
Paiella S; De Pastena M; Romeo F; D'onofrio M; Fontana M; Pea A; De Marchi G; Crinò SF; Bassi C; Salvia R
Minerva Chir; 2019 Jun; 74(3):263-269. PubMed ID: 30600963
[TBL] [Abstract][Full Text] [Related]
3. Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.
Shaib WL; Ip A; Cardona K; Alese OB; Maithel SK; Kooby D; Landry J; El-Rayes BF
Oncologist; 2016 Feb; 21(2):178-87. PubMed ID: 26834159
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.
Mellon EA; Hoffe SE; Springett GM; Frakes JM; Strom TJ; Hodul PJ; Malafa MP; Chuong MD; Shridhar R
Acta Oncol; 2015 Jul; 54(7):979-85. PubMed ID: 25734581
[TBL] [Abstract][Full Text] [Related]
5. Irreversible Electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment?
de Liguori Carino N; O'Reilly DA; Siriwardena AK; Valle JW; Radhakrishna G; Pihlak R; McNamara MG
Eur J Surg Oncol; 2018 Oct; 44(10):1486-1493. PubMed ID: 30146253
[TBL] [Abstract][Full Text] [Related]
6. Multi-disciplinary management of locally advanced pancreatic cancer with irreversible electroporation.
Martin RCG
J Surg Oncol; 2017 Jul; 116(1):35-45. PubMed ID: 28475814
[TBL] [Abstract][Full Text] [Related]
7. Evolving treatment options for locally advanced unresectable pancreatic ductal adenocarcinoma.
Cinar P; Ko AH
J Natl Compr Canc Netw; 2014 Feb; 12(2):167-72. PubMed ID: 24586078
[TBL] [Abstract][Full Text] [Related]
8. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
[TBL] [Abstract][Full Text] [Related]
9. Localized Pancreatic Cancer: Multidisciplinary Management.
Coveler AL; Herman JM; Simeone DM; Chiorean EG
Am Soc Clin Oncol Educ Book; 2016; 35():e217-26. PubMed ID: 27249726
[TBL] [Abstract][Full Text] [Related]
10. Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience.
Nitsche U; Wenzel P; Siveke JT; Braren R; Holzapfel K; Schlitter AM; Stöß C; Kong B; Esposito I; Erkan M; Michalski CW; Friess H; Kleeff J
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1212-20. PubMed ID: 26350368
[TBL] [Abstract][Full Text] [Related]
11. Open irreversible electroporation for isolated local recurrence of pancreatic ductal adenocarcinoma after primary surgery.
Heger U; Mack C; Tjaden C; Pan F; Pausch T; Hinz U; Sommer CM; Hackert T
Pancreatology; 2021 Oct; 21(7):1349-1355. PubMed ID: 34404600
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for pancreatic cancer.
Springfeld C; Jäger D; Büchler MW; Strobel O; Hackert T; Palmer DH; Neoptolemos JP
Presse Med; 2019 Mar; 48(3 Pt 2):e159-e174. PubMed ID: 30879894
[TBL] [Abstract][Full Text] [Related]
13. The use of IRE in multi-modality treatment for oligometastatic pancreatic cancer.
Hong Y; Rice J; Sharma D; Martin RCG
Am J Surg; 2018 Jul; 216(1):106-110. PubMed ID: 29506753
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma.
Loehrer AP; Ferrone CR
Dig Surg; 2016; 33(4):343-50. PubMed ID: 27216011
[TBL] [Abstract][Full Text] [Related]
15. Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis.
He C; Wang J; Sun S; Zhang Y; Lin X; Lao X; Cui B; Li S
BMC Cancer; 2019 Apr; 19(1):394. PubMed ID: 31029111
[TBL] [Abstract][Full Text] [Related]
16. Current State and Future Directions of Radiation Therapy for Pancreas Adenocarcinoma.
Gottumukkala S; Salamekh S; Sanford NN
Surg Oncol Clin N Am; 2023 Jul; 32(3):399-414. PubMed ID: 37182984
[TBL] [Abstract][Full Text] [Related]
17. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
Kwon D; McFarland K; Velanovich V; Martin RC
Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
[TBL] [Abstract][Full Text] [Related]
18. The impact of neoadjuvant therapy on the histopathological features of pancreatic ductal adenocarcinoma - A systematic review and meta-analysis.
Schorn S; Demir IE; Reyes CM; Saricaoglu C; Samm N; Schirren R; Tieftrunk E; Hartmann D; Friess H; Ceyhan GO
Cancer Treat Rev; 2017 Apr; 55():96-106. PubMed ID: 28342938
[TBL] [Abstract][Full Text] [Related]
19. Unresectable locally advanced pancreatic cancer: treatment with neoadjuvant leucovorin, fluorouracil, irinotecan, and oxaliplatin and assessment of surgical resectability.
Mondo EL; Noel MS; Katz AW; Schoeniger LO; Hezel AF
J Clin Oncol; 2013 Jan; 31(3):e37-9. PubMed ID: 23233707
[No Abstract] [Full Text] [Related]
20. Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma.
Marsanic P; Mellano A; Sottile A; De Simone M
Med Biol Eng Comput; 2017 Jul; 55(7):1123-1127. PubMed ID: 28078482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
